These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9333039

  • 21. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
    Nakashima H, Shoji Y, Kim SG, Shimada J, Mizushima Y, Ito M, Yamamoto N, Takaku H.
    Nucleic Acids Res; 1994 Nov 25; 22(23):5004-10. PubMed ID: 7528375
    [Abstract] [Full Text] [Related]

  • 22. Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides.
    Sarih-Cottin L, Bordier B, Musier-Forsyth K, Andreola ML, Barr PJ, Litvak S.
    J Mol Biol; 1992 Jul 05; 226(1):1-6. PubMed ID: 1377751
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
    Inagawa T, Nakashima H, Karwowski B, Guga P, Stec WJ, Takeuchi H, Takaku H.
    FEBS Lett; 2002 Sep 25; 528(1-3):48-52. PubMed ID: 12297278
    [Abstract] [Full Text] [Related]

  • 24. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C, Yelle J, Sauve G, Thierry AR.
    AAPS PharmSci; 2002 Sep 25; 4(2):E9. PubMed ID: 12102618
    [Abstract] [Full Text] [Related]

  • 25. Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme.
    Abbink TE, Beerens N, Berkhout B.
    J Virol; 2004 Oct 25; 78(19):10706-14. PubMed ID: 15367637
    [Abstract] [Full Text] [Related]

  • 26. Interaction of human immunodeficiency virus type 1 reverse transcriptase with primer tRNALys3 and affinity modification of the enzyme by tRNALys3 derivatives.
    Nevinsky GA, Zakharova OD, Fournier M, Andreola ML, Litvak S, Tarrago-Litvak L.
    Eur J Biochem; 1996 Sep 15; 240(3):774-80. PubMed ID: 8856083
    [Abstract] [Full Text] [Related]

  • 27. Structural constraints in the HIV-1 reverse transcriptase-primer/template complex for the initiation of DNA synthesis from primer tRNALys3.
    Zakharova OD, Martiyanov IV, Timofeeva OA, Kolocheva TI, Fournier M, Andreola ML, Maksakova GA, Yamkovoy VI, Litvak S, Tarrago-Litvak L, Nevinsky GA.
    Biochemistry; 1998 Sep 22; 37(38):13343-8. PubMed ID: 9748342
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.
    Hisayoshi T, Shinomura M, Yokokawa K, Kuze I, Konishi A, Kawaji K, Kodama EN, Hata K, Takahashi S, Nirasawa S, Sakuda S, Yasukawa K.
    J Nat Med; 2015 Jul 22; 69(3):432-40. PubMed ID: 25663480
    [Abstract] [Full Text] [Related]

  • 29. HIV-1 reverse transcription initiation: a potential target for novel antivirals?
    Abbink TE, Berkhout B.
    Virus Res; 2008 Jun 22; 134(1-2):4-18. PubMed ID: 18255184
    [Abstract] [Full Text] [Related]

  • 30. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F, Freund F, Moreau S, Nielsen PE, Gryaznov S, Toulmé JJ, Litvak S.
    Nucleic Acids Res; 1998 Dec 01; 26(23):5492-500. PubMed ID: 9826777
    [Abstract] [Full Text] [Related]

  • 31. The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.
    Gerondelis P, Archer RH, Palaniappan C, Reichman RC, Fay PJ, Bambara RA, Demeter LM.
    J Virol; 1999 Jul 01; 73(7):5803-13. PubMed ID: 10364332
    [Abstract] [Full Text] [Related]

  • 32. Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription.
    Huang Y, Shalom A, Li Z, Wang J, Mak J, Wainberg MA, Kleiman L.
    J Virol; 1996 Jul 01; 70(7):4700-6. PubMed ID: 8676496
    [Abstract] [Full Text] [Related]

  • 33. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.
    Liang C, Rong L, Morin N, Cherry E, Huang Y, Kleiman L, Wainberg MA.
    J Virol; 1997 Dec 01; 71(12):9075-86. PubMed ID: 9371564
    [Abstract] [Full Text] [Related]

  • 34. Multiple forms of tRNA(Lys3) in HIV-1.
    Li Z, Shalom A, Huang Y, Mak J, Arts E, Wainberg MA, Kleiman L.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):530-40. PubMed ID: 8878548
    [Abstract] [Full Text] [Related]

  • 35. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.
    Li X, Mak J, Arts EJ, Gu Z, Kleiman L, Wainberg MA, Parniak MA.
    J Virol; 1994 Oct 14; 68(10):6198-206. PubMed ID: 7521916
    [Abstract] [Full Text] [Related]

  • 36. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
    Lavigne C, Yelle J, Sauvé G, Thierry AG.
    AAPS PharmSci; 2001 Oct 14; 3(1):E7. PubMed ID: 11741258
    [Abstract] [Full Text] [Related]

  • 37. In vitro evaluation of the effect of temporary removal of HIV drug pressure.
    Witvrouw M, Pannecouque C, Desmyter J, De Clercq E, Andries K.
    Antiviral Res; 2000 Jun 14; 46(3):215-21. PubMed ID: 10867159
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
    Tsukahara S, Suzuki J, Hiratou T, Takai K, Koyanagi Y, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 1997 Apr 28; 233(3):742-7. PubMed ID: 9168925
    [Abstract] [Full Text] [Related]

  • 39. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A, Meleddu R, Esposito F, Distinto S, Bianco G, Masaoka T, Maccioni E, Menéndez-Arias L, Alcaro S, Le Grice SF, Tramontano E.
    PLoS One; 2016 Apr 28; 11(1):e0147225. PubMed ID: 26800261
    [Abstract] [Full Text] [Related]

  • 40. Identification of HIV-1 reverse transcriptase inhibitors using a scintillation proximity assay.
    Van Schoubroeck B, Van Loock M, Ivens T, Dehertogh P, Jochmans D, Dams G.
    Methods Mol Biol; 2013 Apr 28; 1030():19-24. PubMed ID: 23821257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.